loader image
COVID19 UPDATES
Welcome DG Zacate
previous arrow
next arrow

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2022-1495 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “READING GLASSES (IN FOREIGN CHARACTERS) +1.5”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

FDA Advisory No.2022-1494 || Public Health Warning Against the Purchase and Use of the Following Misbranded Medical Device Product “KF94 (IN FOREIGN CHARACTERS)”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND USE the...
Read More

FDA Advisory No.2022-1484-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2022-1484 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

 The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

FDA Advisory No.2022-1483-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2022-1483 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

FDA Advisory No.2022-1470 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic BAR BILAT VIRGINITY SOAP BY GSKIN

The Food and Drug Administration (FDA) warns the public from purchasing and using the unauthorized cosmetic product, BAR BILAT VIRGINITY...
Read More

FDA Advisory No.2022-1469 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic LIFUHSA COLLAGEN FIRMING GOODNIGHT FROZEN FILM

The Food and Drug Administration (FDA) warns the public from purchasing and using the unauthorized cosmetic product, LIFUHSA COLLAGEN FIRMING...
Read More

FDA Advisory No.2022-1465-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2022-1465 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

Announcement

RESCHEDULE OF QUALIFIED PERSON FOR PHARMACOVIGILANCE SEMINAR (QPPV)
Please be informed that the conduct of QUALIFIED PERSON FOR PHARMACOVIGILANCE SEMINAR (QPPV) on 2 October 2019 within Muntinlupa City shall ...
Read More
SEMINAR VENUE FOR UNIFIED LICENSING SEMINAR (ULS-RXIII) ON 4 SEPTEMBER 2019
Please be informed that the venue of the UNIFIED LICENSING SEMINAR (ULS-RXIII) on 4 September 2019 will be at HOTEL OAZIS, JOSE C ...
Read More
LICENSING SEMINAR FOR ENDS/ENNDS MANUFACTURERS, TRADERS, DISTRIBUTORS, AND RETAILERS
This is to inform all concerned stakeholders that the FDA shall be conducting a licensing seminar for ENDS/ENNDS manufacturers, traders, ...
Read More
Shares